Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3496824rdf:typepubmed:Citationlld:pubmed
pubmed-article:3496824lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:3496824lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3496824lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:3496824lifeskim:mentionsumls-concept:C0814999lld:lifeskim
pubmed-article:3496824lifeskim:mentionsumls-concept:C0034798lld:lifeskim
pubmed-article:3496824lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3496824pubmed:dateCreated1987-7-29lld:pubmed
pubmed-article:3496824pubmed:abstractTextUsing [3H]DA as the ligand of choice, we have shown that rat thymocytes possess dopamine binding sites. The binding of [3H]DA was specific, saturable and of high affinity. [3H]DA binding was rapid and reversible; [3H]DA was totally displaced by low concentrations of dopamine, norepinephrine, and apomorphine. The binding sites were insensitive to neuroleptic drugs such as sulpiride, bromocriptine, and haloperidol. On the basis of these findings, we have suggested that thymocytes possess a D-3 receptor type.lld:pubmed
pubmed-article:3496824pubmed:languageenglld:pubmed
pubmed-article:3496824pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3496824pubmed:citationSubsetIMlld:pubmed
pubmed-article:3496824pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3496824pubmed:statusMEDLINElld:pubmed
pubmed-article:3496824pubmed:issn0077-8923lld:pubmed
pubmed-article:3496824pubmed:authorpubmed-author:AbramskyOOlld:pubmed
pubmed-article:3496824pubmed:authorpubmed-author:OvadiaHHlld:pubmed
pubmed-article:3496824pubmed:authorpubmed-author:Lubetzki-Korn...lld:pubmed
pubmed-article:3496824pubmed:issnTypePrintlld:pubmed
pubmed-article:3496824pubmed:volume496lld:pubmed
pubmed-article:3496824pubmed:ownerNLMlld:pubmed
pubmed-article:3496824pubmed:authorsCompleteYlld:pubmed
pubmed-article:3496824pubmed:pagination211-6lld:pubmed
pubmed-article:3496824pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:meshHeadingpubmed-meshheading:3496824-...lld:pubmed
pubmed-article:3496824pubmed:year1987lld:pubmed
pubmed-article:3496824pubmed:articleTitleDopamine receptors on isolated membranes of rat thymocytes.lld:pubmed
pubmed-article:3496824pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3496824lld:pubmed